Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer

Original Article

T. Powles, J.W. Catto, M.D. Galsky, H. Al-Ahmadie, J.J. Meeks, H. Nishiyama, T.Q. Vu, L. Antonuzzo, P. Wiechno, V. Atduev, A.G. Kann, T.-H. Kim, C. Suárez, C.-H. Chang, F. Roghmann, M. Özgüroğlu, B.J. Eigl, N. Oliveira, T. Buchler, M. Gadot, Y. Zakharia, J. Armstrong, A. Gupta, S. Hois, and M.S.v.d. Heijden

N Engl J Med 2024;391:1773-1786

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
11/13/2024
Course expires: 
11/14/2026

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please sign in or create an account to take the course.